NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
24,577,317
Share change
-80,295
Total reported value
$46,280,000
Put/Call ratio
0%
Price per share
$1.88
Number of holders
78
Value change
-$3,973,496
Number of buys
38
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q1 2022

As of 31 Mar 2022, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,577,317 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Redmile Group, LLC, PICTET ASSET MANAGEMENT SA, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., Opaleye Management Inc., and Candriam Luxembourg S.C.A.. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.